Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-06-25

FDA Approved: NITROFURANTOIN — Original Application (Alembic Pharmaceuticals Limited)

View source ↗

Summary

FDA approves Alembic Pharmaceuticals Limited's original application for nitrofurantoin, a generic antibiotic for urinary tract infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nitrofurantoin (Nitrofurantoin)

Snippet

ORIG AP for NITROFURANTOIN (NITROFURANTOIN)